Webinar: Join industry bigwigs in exploring the new normal for Pharma industry
Placed under Essential Services category, the pharmaceutical industry has been having a busy time amid the COVID-19 period and throughout the nation-wide lockdown. However, the world’s third largest drug producer in terms of volumes has not remained immune to the uncertainties of the economy, massive disruption in supply chain, especially import of active pharmaceutical ingredients from China, and en masse return of the migrant labour force to their native places.
As India begins its lockdown exit strategy with easing of restrictions in a phased manner, the pharma industry is pulling out all stops to ensure that the production of medicines and essentials to fight the COVID-19 pandemic continues without much hindrance. In an unprecedented move, all major companies have come together to help one another with knowledge and sharing of resources.
On the other hand, healthcare professionals such as doctors, nurses, ambulance crew are under severe strain, with quite a few themselves infected in their line of duty. Nursing homes and clinics are temporarily closed. Many doctors have paused their practice to follow social distancing and stay away from the virus. However, this has given rise to the opportunity of telemedicine and consultation over phone or online. As in the case of the rest of the industry, it will be a long while before normalcy is restored in the pharma industry. What will it take for the pharma industry to be back on track – is the burning question.
Adgully has lined up some of the best brains in the healthcare space to chart out the future course for the pharma industry in India as part of our special Webinar series:
Shashin Bodawala, Director – Business Excellence, Go To Market & International Business, Boehringer Ingelheim – Moderator
Praful Akali, Founder & MD, Medulla Communications
Salil S Kallianpur, Founder & MD, ARKS Knowledge Pvt Ltd
Sangeeta Barde, Managing Partner, Havas Life Sorento, Havas Health & You Group
Titled ‘Pandemic & Big Pharma: A Bitter Pill or A Shot In The Arm’, the live Webinar session will be held Thursday, May 7, 2020, between 4 pm and 5 pm. Prior registration is mandatory to login to the session. Please note that there is no registration fee.